Xue He
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis.
Journal: Pediatric nephrology (Berlin, Germany)
Published: December 05, 2024
Successful outcome of a refractory IgA vasculitis nephritis in children treated with telitacicept.
Journal: CEN case reports
Published: December 05, 2024
Serum cytokine profiles in children with IgA vasculitis with nephritis.
Journal: Biomolecules & biomedicine
Published: August 01, 2024
Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome.
Journal: Clinical kidney journal
Published: June 21, 2024
ALKBH5 insufficiency protects against ferroptosis-driven cisplatin-induced renal cytotoxicity.
Journal: Cell biology and toxicology
Published: May 03, 2024
Glomerular diseases after immune checkpoint inhibitors use: What do We know so far?
Journal: Renal failure
Published: November 24, 2022
Case Report: Membranoproliferative Glomerulonephritis, a Rare Clinical Manifestation of Abernethy Malformation Type II.
Journal: Frontiers in pediatrics
Published: December 29, 2020
INTEDE: interactome of drug-metabolizing enzymes.
Journal: Nucleic acids research
Published: July 20, 2020
Reduced anogenital distance, hematuria and left renal hypoplasia in a patient with 13q33.1-34 deletion: case report and literature review.
Journal: BMC pediatrics
Published: March 24, 2020
Establishment and identification of a hypoxia-ischemia brain damage model in neonatal rats.
Journal: Biomedical reports
Published: December 01, 2015
Last Updated: 09/26/2026